Global Oral Anti-allergic Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 111

Published Date: 22 Mar 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Oral Anti-allergic Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Oral Anti-allergic Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Oral Anti-allergic Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oral Anti-allergic Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oral Anti-allergic Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oral Anti-allergic Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oral Anti-allergic Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oral Anti-allergic Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Johnson & Johnson, Merck, Teva and GlaxoSmithKline, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Oral Anti-allergic Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Antihistamine Drugs
    Allergic Mediator Release Agent
    Immunosuppressant Drugs

Market segment by Application
    Hospital Pharmacies
    Retail Pharmacies
    Online Pharmacies

Major players covered
    Sanofi
    Johnson & Johnson
    Merck
    Teva
    GlaxoSmithKline
    Bayer
    Almirall
    Pfizer
    AstraZeneca
    Sun Pharma
    Novartis
    Boehringer Ingelheim
    UCB Pharma
    Yangtze River Pharmaceutical Group
    Hainan Poly Pharm
    Chongqing Huapont Pharmaceutical
    Dawnrays Pharma

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral Anti-allergic Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral Anti-allergic Drugs, with price, sales, revenue and global market share of Oral Anti-allergic Drugs from 2018 to 2023.
Chapter 3, the Oral Anti-allergic Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral Anti-allergic Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oral Anti-allergic Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Anti-allergic Drugs.
Chapter 14 and 15, to describe Oral Anti-allergic Drugs sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Oral Anti-allergic Drugs
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Oral Anti-allergic Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Antihistamine Drugs
        1.3.3 Allergic Mediator Release Agent
        1.3.4 Immunosuppressant Drugs
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Oral Anti-allergic Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital Pharmacies
        1.4.3 Retail Pharmacies
        1.4.4 Online Pharmacies
    1.5 Global Oral Anti-allergic Drugs Market Size & Forecast
        1.5.1 Global Oral Anti-allergic Drugs Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Oral Anti-allergic Drugs Sales Quantity (2018-2029)
        1.5.3 Global Oral Anti-allergic Drugs Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Sanofi
        2.1.1 Sanofi Details
        2.1.2 Sanofi Major Business
        2.1.3 Sanofi Oral Anti-allergic Drugs Product and Services
        2.1.4 Sanofi Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Sanofi Recent Developments/Updates
    2.2 Johnson & Johnson
        2.2.1 Johnson & Johnson Details
        2.2.2 Johnson & Johnson Major Business
        2.2.3 Johnson & Johnson Oral Anti-allergic Drugs Product and Services
        2.2.4 Johnson & Johnson Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Johnson & Johnson Recent Developments/Updates
    2.3 Merck
        2.3.1 Merck Details
        2.3.2 Merck Major Business
        2.3.3 Merck Oral Anti-allergic Drugs Product and Services
        2.3.4 Merck Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Merck Recent Developments/Updates
    2.4 Teva
        2.4.1 Teva Details
        2.4.2 Teva Major Business
        2.4.3 Teva Oral Anti-allergic Drugs Product and Services
        2.4.4 Teva Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Teva Recent Developments/Updates
    2.5 GlaxoSmithKline
        2.5.1 GlaxoSmithKline Details
        2.5.2 GlaxoSmithKline Major Business
        2.5.3 GlaxoSmithKline Oral Anti-allergic Drugs Product and Services
        2.5.4 GlaxoSmithKline Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 GlaxoSmithKline Recent Developments/Updates
    2.6 Bayer
        2.6.1 Bayer Details
        2.6.2 Bayer Major Business
        2.6.3 Bayer Oral Anti-allergic Drugs Product and Services
        2.6.4 Bayer Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Bayer Recent Developments/Updates
    2.7 Almirall
        2.7.1 Almirall Details
        2.7.2 Almirall Major Business
        2.7.3 Almirall Oral Anti-allergic Drugs Product and Services
        2.7.4 Almirall Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Almirall Recent Developments/Updates
    2.8 Pfizer
        2.8.1 Pfizer Details
        2.8.2 Pfizer Major Business
        2.8.3 Pfizer Oral Anti-allergic Drugs Product and Services
        2.8.4 Pfizer Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Pfizer Recent Developments/Updates
    2.9 AstraZeneca
        2.9.1 AstraZeneca Details
        2.9.2 AstraZeneca Major Business
        2.9.3 AstraZeneca Oral Anti-allergic Drugs Product and Services
        2.9.4 AstraZeneca Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 AstraZeneca Recent Developments/Updates
    2.10 Sun Pharma
        2.10.1 Sun Pharma Details
        2.10.2 Sun Pharma Major Business
        2.10.3 Sun Pharma Oral Anti-allergic Drugs Product and Services
        2.10.4 Sun Pharma Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 Sun Pharma Recent Developments/Updates
    2.11 Novartis
        2.11.1 Novartis Details
        2.11.2 Novartis Major Business
        2.11.3 Novartis Oral Anti-allergic Drugs Product and Services
        2.11.4 Novartis Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Novartis Recent Developments/Updates
    2.12 Boehringer Ingelheim
        2.12.1 Boehringer Ingelheim Details
        2.12.2 Boehringer Ingelheim Major Business
        2.12.3 Boehringer Ingelheim Oral Anti-allergic Drugs Product and Services
        2.12.4 Boehringer Ingelheim Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 Boehringer Ingelheim Recent Developments/Updates
    2.13 UCB Pharma
        2.13.1 UCB Pharma Details
        2.13.2 UCB Pharma Major Business
        2.13.3 UCB Pharma Oral Anti-allergic Drugs Product and Services
        2.13.4 UCB Pharma Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.13.5 UCB Pharma Recent Developments/Updates
    2.14 Yangtze River Pharmaceutical Group
        2.14.1 Yangtze River Pharmaceutical Group Details
        2.14.2 Yangtze River Pharmaceutical Group Major Business
        2.14.3 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Product and Services
        2.14.4 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.14.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
    2.15 Hainan Poly Pharm
        2.15.1 Hainan Poly Pharm Details
        2.15.2 Hainan Poly Pharm Major Business
        2.15.3 Hainan Poly Pharm Oral Anti-allergic Drugs Product and Services
        2.15.4 Hainan Poly Pharm Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.15.5 Hainan Poly Pharm Recent Developments/Updates
    2.16 Chongqing Huapont Pharmaceutical
        2.16.1 Chongqing Huapont Pharmaceutical Details
        2.16.2 Chongqing Huapont Pharmaceutical Major Business
        2.16.3 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Product and Services
        2.16.4 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.16.5 Chongqing Huapont Pharmaceutical Recent Developments/Updates
    2.17 Dawnrays Pharma
        2.17.1 Dawnrays Pharma Details
        2.17.2 Dawnrays Pharma Major Business
        2.17.3 Dawnrays Pharma Oral Anti-allergic Drugs Product and Services
        2.17.4 Dawnrays Pharma Oral Anti-allergic Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.17.5 Dawnrays Pharma Recent Developments/Updates

3 Competitive Environment: Oral Anti-allergic Drugs by Manufacturer
    3.1 Global Oral Anti-allergic Drugs Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Oral Anti-allergic Drugs Revenue by Manufacturer (2018-2023)
    3.3 Global Oral Anti-allergic Drugs Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Oral Anti-allergic Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Oral Anti-allergic Drugs Manufacturer Market Share in 2022
        3.4.2 Top 6 Oral Anti-allergic Drugs Manufacturer Market Share in 2022
    3.5 Oral Anti-allergic Drugs Market: Overall Company Footprint Analysis
        3.5.1 Oral Anti-allergic Drugs Market: Region Footprint
        3.5.2 Oral Anti-allergic Drugs Market: Company Product Type Footprint
        3.5.3 Oral Anti-allergic Drugs Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Oral Anti-allergic Drugs Market Size by Region
        4.1.1 Global Oral Anti-allergic Drugs Sales Quantity by Region (2018-2029)
        4.1.2 Global Oral Anti-allergic Drugs Consumption Value by Region (2018-2029)
        4.1.3 Global Oral Anti-allergic Drugs Average Price by Region (2018-2029)
    4.2 North America Oral Anti-allergic Drugs Consumption Value (2018-2029)
    4.3 Europe Oral Anti-allergic Drugs Consumption Value (2018-2029)
    4.4 Asia-Pacific Oral Anti-allergic Drugs Consumption Value (2018-2029)
    4.5 South America Oral Anti-allergic Drugs Consumption Value (2018-2029)
    4.6 Middle East and Africa Oral Anti-allergic Drugs Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Oral Anti-allergic Drugs Sales Quantity by Type (2018-2029)
    5.2 Global Oral Anti-allergic Drugs Consumption Value by Type (2018-2029)
    5.3 Global Oral Anti-allergic Drugs Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Oral Anti-allergic Drugs Sales Quantity by Application (2018-2029)
    6.2 Global Oral Anti-allergic Drugs Consumption Value by Application (2018-2029)
    6.3 Global Oral Anti-allergic Drugs Average Price by Application (2018-2029)

7 North America
    7.1 North America Oral Anti-allergic Drugs Sales Quantity by Type (2018-2029)
    7.2 North America Oral Anti-allergic Drugs Sales Quantity by Application (2018-2029)
    7.3 North America Oral Anti-allergic Drugs Market Size by Country
        7.3.1 North America Oral Anti-allergic Drugs Sales Quantity by Country (2018-2029)
        7.3.2 North America Oral Anti-allergic Drugs Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Oral Anti-allergic Drugs Sales Quantity by Type (2018-2029)
    8.2 Europe Oral Anti-allergic Drugs Sales Quantity by Application (2018-2029)
    8.3 Europe Oral Anti-allergic Drugs Market Size by Country
        8.3.1 Europe Oral Anti-allergic Drugs Sales Quantity by Country (2018-2029)
        8.3.2 Europe Oral Anti-allergic Drugs Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Oral Anti-allergic Drugs Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Oral Anti-allergic Drugs Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Oral Anti-allergic Drugs Market Size by Region
        9.3.1 Asia-Pacific Oral Anti-allergic Drugs Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Oral Anti-allergic Drugs Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Oral Anti-allergic Drugs Sales Quantity by Type (2018-2029)
    10.2 South America Oral Anti-allergic Drugs Sales Quantity by Application (2018-2029)
    10.3 South America Oral Anti-allergic Drugs Market Size by Country
        10.3.1 South America Oral Anti-allergic Drugs Sales Quantity by Country (2018-2029)
        10.3.2 South America Oral Anti-allergic Drugs Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Oral Anti-allergic Drugs Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Oral Anti-allergic Drugs Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Oral Anti-allergic Drugs Market Size by Country
        11.3.1 Middle East & Africa Oral Anti-allergic Drugs Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Oral Anti-allergic Drugs Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Oral Anti-allergic Drugs Market Drivers
    12.2 Oral Anti-allergic Drugs Market Restraints
    12.3 Oral Anti-allergic Drugs Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Oral Anti-allergic Drugs and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Oral Anti-allergic Drugs
    13.3 Oral Anti-allergic Drugs Production Process
    13.4 Oral Anti-allergic Drugs Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Oral Anti-allergic Drugs Typical Distributors
    14.3 Oral Anti-allergic Drugs Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Oral Anti-allergic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Oral Anti-allergic Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
    Table 4. Sanofi Major Business
    Table 5. Sanofi Oral Anti-allergic Drugs Product and Services
    Table 6. Sanofi Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Sanofi Recent Developments/Updates
    Table 8. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
    Table 9. Johnson & Johnson Major Business
    Table 10. Johnson & Johnson Oral Anti-allergic Drugs Product and Services
    Table 11. Johnson & Johnson Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Johnson & Johnson Recent Developments/Updates
    Table 13. Merck Basic Information, Manufacturing Base and Competitors
    Table 14. Merck Major Business
    Table 15. Merck Oral Anti-allergic Drugs Product and Services
    Table 16. Merck Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Merck Recent Developments/Updates
    Table 18. Teva Basic Information, Manufacturing Base and Competitors
    Table 19. Teva Major Business
    Table 20. Teva Oral Anti-allergic Drugs Product and Services
    Table 21. Teva Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Teva Recent Developments/Updates
    Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
    Table 24. GlaxoSmithKline Major Business
    Table 25. GlaxoSmithKline Oral Anti-allergic Drugs Product and Services
    Table 26. GlaxoSmithKline Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. GlaxoSmithKline Recent Developments/Updates
    Table 28. Bayer Basic Information, Manufacturing Base and Competitors
    Table 29. Bayer Major Business
    Table 30. Bayer Oral Anti-allergic Drugs Product and Services
    Table 31. Bayer Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Bayer Recent Developments/Updates
    Table 33. Almirall Basic Information, Manufacturing Base and Competitors
    Table 34. Almirall Major Business
    Table 35. Almirall Oral Anti-allergic Drugs Product and Services
    Table 36. Almirall Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Almirall Recent Developments/Updates
    Table 38. Pfizer Basic Information, Manufacturing Base and Competitors
    Table 39. Pfizer Major Business
    Table 40. Pfizer Oral Anti-allergic Drugs Product and Services
    Table 41. Pfizer Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Pfizer Recent Developments/Updates
    Table 43. AstraZeneca Basic Information, Manufacturing Base and Competitors
    Table 44. AstraZeneca Major Business
    Table 45. AstraZeneca Oral Anti-allergic Drugs Product and Services
    Table 46. AstraZeneca Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. AstraZeneca Recent Developments/Updates
    Table 48. Sun Pharma Basic Information, Manufacturing Base and Competitors
    Table 49. Sun Pharma Major Business
    Table 50. Sun Pharma Oral Anti-allergic Drugs Product and Services
    Table 51. Sun Pharma Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. Sun Pharma Recent Developments/Updates
    Table 53. Novartis Basic Information, Manufacturing Base and Competitors
    Table 54. Novartis Major Business
    Table 55. Novartis Oral Anti-allergic Drugs Product and Services
    Table 56. Novartis Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Novartis Recent Developments/Updates
    Table 58. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
    Table 59. Boehringer Ingelheim Major Business
    Table 60. Boehringer Ingelheim Oral Anti-allergic Drugs Product and Services
    Table 61. Boehringer Ingelheim Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. Boehringer Ingelheim Recent Developments/Updates
    Table 63. UCB Pharma Basic Information, Manufacturing Base and Competitors
    Table 64. UCB Pharma Major Business
    Table 65. UCB Pharma Oral Anti-allergic Drugs Product and Services
    Table 66. UCB Pharma Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 67. UCB Pharma Recent Developments/Updates
    Table 68. Yangtze River Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
    Table 69. Yangtze River Pharmaceutical Group Major Business
    Table 70. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Product and Services
    Table 71. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 72. Yangtze River Pharmaceutical Group Recent Developments/Updates
    Table 73. Hainan Poly Pharm Basic Information, Manufacturing Base and Competitors
    Table 74. Hainan Poly Pharm Major Business
    Table 75. Hainan Poly Pharm Oral Anti-allergic Drugs Product and Services
    Table 76. Hainan Poly Pharm Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Hainan Poly Pharm Recent Developments/Updates
    Table 78. Chongqing Huapont Pharmaceutical Basic Information, Manufacturing Base and Competitors
    Table 79. Chongqing Huapont Pharmaceutical Major Business
    Table 80. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Product and Services
    Table 81. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 82. Chongqing Huapont Pharmaceutical Recent Developments/Updates
    Table 83. Dawnrays Pharma Basic Information, Manufacturing Base and Competitors
    Table 84. Dawnrays Pharma Major Business
    Table 85. Dawnrays Pharma Oral Anti-allergic Drugs Product and Services
    Table 86. Dawnrays Pharma Oral Anti-allergic Drugs Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 87. Dawnrays Pharma Recent Developments/Updates
    Table 88. Global Oral Anti-allergic Drugs Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 89. Global Oral Anti-allergic Drugs Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 90. Global Oral Anti-allergic Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 91. Market Position of Manufacturers in Oral Anti-allergic Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 92. Head Office and Oral Anti-allergic Drugs Production Site of Key Manufacturer
    Table 93. Oral Anti-allergic Drugs Market: Company Product Type Footprint
    Table 94. Oral Anti-allergic Drugs Market: Company Product Application Footprint
    Table 95. Oral Anti-allergic Drugs New Market Entrants and Barriers to Market Entry
    Table 96. Oral Anti-allergic Drugs Mergers, Acquisition, Agreements, and Collaborations
    Table 97. Global Oral Anti-allergic Drugs Sales Quantity by Region (2018-2023) & (K Units)
    Table 98. Global Oral Anti-allergic Drugs Sales Quantity by Region (2024-2029) & (K Units)
    Table 99. Global Oral Anti-allergic Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 100. Global Oral Anti-allergic Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 101. Global Oral Anti-allergic Drugs Average Price by Region (2018-2023) & (US$/Unit)
    Table 102. Global Oral Anti-allergic Drugs Average Price by Region (2024-2029) & (US$/Unit)
    Table 103. Global Oral Anti-allergic Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 104. Global Oral Anti-allergic Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 105. Global Oral Anti-allergic Drugs Consumption Value by Type (2018-2023) & (USD Million)
    Table 106. Global Oral Anti-allergic Drugs Consumption Value by Type (2024-2029) & (USD Million)
    Table 107. Global Oral Anti-allergic Drugs Average Price by Type (2018-2023) & (US$/Unit)
    Table 108. Global Oral Anti-allergic Drugs Average Price by Type (2024-2029) & (US$/Unit)
    Table 109. Global Oral Anti-allergic Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 110. Global Oral Anti-allergic Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 111. Global Oral Anti-allergic Drugs Consumption Value by Application (2018-2023) & (USD Million)
    Table 112. Global Oral Anti-allergic Drugs Consumption Value by Application (2024-2029) & (USD Million)
    Table 113. Global Oral Anti-allergic Drugs Average Price by Application (2018-2023) & (US$/Unit)
    Table 114. Global Oral Anti-allergic Drugs Average Price by Application (2024-2029) & (US$/Unit)
    Table 115. North America Oral Anti-allergic Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 116. North America Oral Anti-allergic Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 117. North America Oral Anti-allergic Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 118. North America Oral Anti-allergic Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 119. North America Oral Anti-allergic Drugs Sales Quantity by Country (2018-2023) & (K Units)
    Table 120. North America Oral Anti-allergic Drugs Sales Quantity by Country (2024-2029) & (K Units)
    Table 121. North America Oral Anti-allergic Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 122. North America Oral Anti-allergic Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 123. Europe Oral Anti-allergic Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 124. Europe Oral Anti-allergic Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 125. Europe Oral Anti-allergic Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 126. Europe Oral Anti-allergic Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 127. Europe Oral Anti-allergic Drugs Sales Quantity by Country (2018-2023) & (K Units)
    Table 128. Europe Oral Anti-allergic Drugs Sales Quantity by Country (2024-2029) & (K Units)
    Table 129. Europe Oral Anti-allergic Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 130. Europe Oral Anti-allergic Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 131. Asia-Pacific Oral Anti-allergic Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 132. Asia-Pacific Oral Anti-allergic Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 133. Asia-Pacific Oral Anti-allergic Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 134. Asia-Pacific Oral Anti-allergic Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 135. Asia-Pacific Oral Anti-allergic Drugs Sales Quantity by Region (2018-2023) & (K Units)
    Table 136. Asia-Pacific Oral Anti-allergic Drugs Sales Quantity by Region (2024-2029) & (K Units)
    Table 137. Asia-Pacific Oral Anti-allergic Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 138. Asia-Pacific Oral Anti-allergic Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 139. South America Oral Anti-allergic Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 140. South America Oral Anti-allergic Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 141. South America Oral Anti-allergic Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 142. South America Oral Anti-allergic Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 143. South America Oral Anti-allergic Drugs Sales Quantity by Country (2018-2023) & (K Units)
    Table 144. South America Oral Anti-allergic Drugs Sales Quantity by Country (2024-2029) & (K Units)
    Table 145. South America Oral Anti-allergic Drugs Consumption Value by Country (2018-2023) & (USD Million)
    Table 146. South America Oral Anti-allergic Drugs Consumption Value by Country (2024-2029) & (USD Million)
    Table 147. Middle East & Africa Oral Anti-allergic Drugs Sales Quantity by Type (2018-2023) & (K Units)
    Table 148. Middle East & Africa Oral Anti-allergic Drugs Sales Quantity by Type (2024-2029) & (K Units)
    Table 149. Middle East & Africa Oral Anti-allergic Drugs Sales Quantity by Application (2018-2023) & (K Units)
    Table 150. Middle East & Africa Oral Anti-allergic Drugs Sales Quantity by Application (2024-2029) & (K Units)
    Table 151. Middle East & Africa Oral Anti-allergic Drugs Sales Quantity by Region (2018-2023) & (K Units)
    Table 152. Middle East & Africa Oral Anti-allergic Drugs Sales Quantity by Region (2024-2029) & (K Units)
    Table 153. Middle East & Africa Oral Anti-allergic Drugs Consumption Value by Region (2018-2023) & (USD Million)
    Table 154. Middle East & Africa Oral Anti-allergic Drugs Consumption Value by Region (2024-2029) & (USD Million)
    Table 155. Oral Anti-allergic Drugs Raw Material
    Table 156. Key Manufacturers of Oral Anti-allergic Drugs Raw Materials
    Table 157. Oral Anti-allergic Drugs Typical Distributors
    Table 158. Oral Anti-allergic Drugs Typical Customers
List of Figures
    Figure 1. Oral Anti-allergic Drugs Picture
    Figure 2. Global Oral Anti-allergic Drugs Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Oral Anti-allergic Drugs Consumption Value Market Share by Type in 2022
    Figure 4. Antihistamine Drugs Examples
    Figure 5. Allergic Mediator Release Agent Examples
    Figure 6. Immunosuppressant Drugs Examples
    Figure 7. Global Oral Anti-allergic Drugs Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global Oral Anti-allergic Drugs Consumption Value Market Share by Application in 2022
    Figure 9. Hospital Pharmacies Examples
    Figure 10. Retail Pharmacies Examples
    Figure 11. Online Pharmacies Examples
    Figure 12. Global Oral Anti-allergic Drugs Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 13. Global Oral Anti-allergic Drugs Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 14. Global Oral Anti-allergic Drugs Sales Quantity (2018-2029) & (K Units)
    Figure 15. Global Oral Anti-allergic Drugs Average Price (2018-2029) & (US$/Unit)
    Figure 16. Global Oral Anti-allergic Drugs Sales Quantity Market Share by Manufacturer in 2022
    Figure 17. Global Oral Anti-allergic Drugs Consumption Value Market Share by Manufacturer in 2022
    Figure 18. Producer Shipments of Oral Anti-allergic Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 19. Top 3 Oral Anti-allergic Drugs Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Top 6 Oral Anti-allergic Drugs Manufacturer (Consumption Value) Market Share in 2022
    Figure 21. Global Oral Anti-allergic Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 22. Global Oral Anti-allergic Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 23. North America Oral Anti-allergic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 24. Europe Oral Anti-allergic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 25. Asia-Pacific Oral Anti-allergic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 26. South America Oral Anti-allergic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 27. Middle East & Africa Oral Anti-allergic Drugs Consumption Value (2018-2029) & (USD Million)
    Figure 28. Global Oral Anti-allergic Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 29. Global Oral Anti-allergic Drugs Consumption Value Market Share by Type (2018-2029)
    Figure 30. Global Oral Anti-allergic Drugs Average Price by Type (2018-2029) & (US$/Unit)
    Figure 31. Global Oral Anti-allergic Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 32. Global Oral Anti-allergic Drugs Consumption Value Market Share by Application (2018-2029)
    Figure 33. Global Oral Anti-allergic Drugs Average Price by Application (2018-2029) & (US$/Unit)
    Figure 34. North America Oral Anti-allergic Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 35. North America Oral Anti-allergic Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 36. North America Oral Anti-allergic Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 37. North America Oral Anti-allergic Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 38. United States Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Canada Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Mexico Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 41. Europe Oral Anti-allergic Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 42. Europe Oral Anti-allergic Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 43. Europe Oral Anti-allergic Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 44. Europe Oral Anti-allergic Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 45. Germany Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. France Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. United Kingdom Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Russia Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Italy Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 50. Asia-Pacific Oral Anti-allergic Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 51. Asia-Pacific Oral Anti-allergic Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 52. Asia-Pacific Oral Anti-allergic Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 53. Asia-Pacific Oral Anti-allergic Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 54. China Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Japan Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. Korea Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. India Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Southeast Asia Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. Australia Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 60. South America Oral Anti-allergic Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 61. South America Oral Anti-allergic Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 62. South America Oral Anti-allergic Drugs Sales Quantity Market Share by Country (2018-2029)
    Figure 63. South America Oral Anti-allergic Drugs Consumption Value Market Share by Country (2018-2029)
    Figure 64. Brazil Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Argentina Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 66. Middle East & Africa Oral Anti-allergic Drugs Sales Quantity Market Share by Type (2018-2029)
    Figure 67. Middle East & Africa Oral Anti-allergic Drugs Sales Quantity Market Share by Application (2018-2029)
    Figure 68. Middle East & Africa Oral Anti-allergic Drugs Sales Quantity Market Share by Region (2018-2029)
    Figure 69. Middle East & Africa Oral Anti-allergic Drugs Consumption Value Market Share by Region (2018-2029)
    Figure 70. Turkey Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Egypt Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. Saudi Arabia Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. South Africa Oral Anti-allergic Drugs Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 74. Oral Anti-allergic Drugs Market Drivers
    Figure 75. Oral Anti-allergic Drugs Market Restraints
    Figure 76. Oral Anti-allergic Drugs Market Trends
    Figure 77. Porters Five Forces Analysis
    Figure 78. Manufacturing Cost Structure Analysis of Oral Anti-allergic Drugs in 2022
    Figure 79. Manufacturing Process Analysis of Oral Anti-allergic Drugs
    Figure 80. Oral Anti-allergic Drugs Industrial Chain
    Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 82. Direct Channel Pros & Cons
    Figure 83. Indirect Channel Pros & Cons
    Figure 84. Methodology
    Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Oral Anti-allergic Drugs Supply, Demand and Key Producers, 2023-2029

Global Oral Anti-allergic Drugs Supply, Demand and Key Producers, 2023-2029

date 22 Mar 2023

date Pharma & Healthcare

The global Oral Anti-allergic Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Oral Anti-allergic Drugs Supply, Demand and Key Producers, 2024-2030

Global Oral Anti-allergic Drugs Supply, Demand and Key Producers, 2024-2030

date 14 Feb 2024

date Pharma & Healthcare

The global Oral Anti-allergic Drugs market size is expected to reach $ 36620 million by 2030, rising at a market growth of 3.6% CAGR during the forecast period (2024-2030).

Product Tags

Oral Anti-allergic Drugs

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>